176 related articles for article (PubMed ID: 30538219)
1. Multidrug-resistant tuberculosis (MDR-TB) strain infection in macaques results in high bacilli burdens in airways, driving broad innate/adaptive immune responses.
Yang E; Yang R; Guo M; Huang D; Wang W; Zhang Z; Chen C; Wang F; Ho W; Shen L; Xiao H; Chen ZW; Shen H
Emerg Microbes Infect; 2018 Dec; 7(1):207. PubMed ID: 30538219
[TBL] [Abstract][Full Text] [Related]
2. Patients with multidrug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains.
Geffner L; Yokobori N; Basile J; Schierloh P; Balboa L; Romero MM; Ritacco V; Vescovo M; González Montaner P; Lopez B; Barrera L; Alemán M; Abatte E; Sasiain MC; de la Barrera S
Infect Immun; 2009 Nov; 77(11):5025-34. PubMed ID: 19720756
[TBL] [Abstract][Full Text] [Related]
3. Th22 response induced by Mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multi-drug-resistant tuberculosis.
Imperiale BR; García A; Minotti A; González Montaner P; Moracho L; Morcillo NS; Palmero DJ; Sasiain MDC; de la Barrera S
Clin Exp Immunol; 2021 Feb; 203(2):267-280. PubMed ID: 33128773
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis multi-drug-resistant strain M induces IL-17
Basile JI; Kviatcovsky D; Romero MM; Balboa L; Monteserin J; Ritacco V; Lopez B; Sabio y García C; García A; Vescovo M; Montaner PG; Palmero D; Del Carmen Sasiain M; de la Barrera S
Clin Exp Immunol; 2017 Jan; 187(1):160-173. PubMed ID: 27681197
[TBL] [Abstract][Full Text] [Related]
5. CD4+ T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ T and CD3- lymphocytes: mechanisms of CD4+ T cell immunity.
Yao S; Huang D; Chen CY; Halliday L; Wang RC; Chen ZW
J Immunol; 2014 Mar; 192(5):2120-32. PubMed ID: 24489088
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive Zoledronate + IL-2 administrations enhance anti-tuberculosis Vγ2Vδ2 T-effector populations, and improve treatment outcome of multidrug-resistant tuberculosis
Shen H; Yang E; Guo M; Yang R; Huang G; Peng Y; Sha W; Wang F; Shen L
Emerg Microbes Infect; 2022 Dec; 11(1):1790-1805. PubMed ID: 35765887
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Th1- and Th2-type immune response in human multidrug-resistant tuberculosis.
Tan Q; Xie WP; Min R; Dai GQ; Xu CC; Pan HQ; Miao CD; Yang Z; Xu WG; Wang H
Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):1233-42. PubMed ID: 22042558
[TBL] [Abstract][Full Text] [Related]
8. Reduced virulence of an extensively drug-resistant outbreak strain of Mycobacterium tuberculosis in a murine model.
Smith KL; Saini D; Bardarov S; Larsen M; Frothingham R; Gandhi NR; Jacobs WR; Sturm AW; Lee S
PLoS One; 2014; 9(4):e94953. PubMed ID: 24733050
[TBL] [Abstract][Full Text] [Related]
9. Radiological findings of extensively drug-resistant pulmonary tuberculosis in non-AIDS adults: comparisons with findings of multidrug-resistant and drug-sensitive tuberculosis.
Cha J; Lee HY; Lee KS; Koh WJ; Kwon OJ; Yi CA; Kim TS; Chung MJ
Korean J Radiol; 2009; 10(3):207-16. PubMed ID: 19412508
[TBL] [Abstract][Full Text] [Related]
10. The phytochemical bergenin as an adjunct immunotherapy for tuberculosis in mice.
Kumar S; Sharma C; Kaushik SR; Kulshreshtha A; Chaturvedi S; Nanda RK; Bhaskar A; Chattopadhyay D; Das G; Dwivedi VP
J Biol Chem; 2019 May; 294(21):8555-8563. PubMed ID: 30975902
[TBL] [Abstract][Full Text] [Related]
11. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
Front Immunol; 2014; 5():180. PubMed ID: 24795723
[TBL] [Abstract][Full Text] [Related]
12. Leukocytes from Patients with Drug-Sensitive and Multidrug-Resistant Tuberculosis Exhibit Distinctive Profiles of Chemokine Receptor Expression and Migration Capacity.
Ocaña-Guzmán R; Téllez-Navarrete NA; Ramón-Luing LA; Herrera I; De Ita M; Carrillo-Alduenda JL; Choreño-Parra JA; Medina-Quero K; Zúñiga J; Chávez-Galán L
J Immunol Res; 2021; 2021():6654220. PubMed ID: 33977111
[TBL] [Abstract][Full Text] [Related]
13. The Activities and Secretion of Cytokines Caused by Delamanid on Macrophages Infected by Multidrug-Resistant
Lyu XL; Lin TT; Gao JT; Jia HY; Zhu CZ; Li ZH; Dong J; Sun Q; Shu W; Pan LP; Zhang ZD; Li Q
Front Immunol; 2021; 12():796677. PubMed ID: 35003120
[TBL] [Abstract][Full Text] [Related]
14. CD4(+)FoxP3(+) T regulatory cells in drug-susceptible and multidrug-resistant tuberculosis.
Lim HJ; Park JS; Cho YJ; Yoon HI; Park KU; Lee CT; Lee JH
Tuberculosis (Edinb); 2013 Sep; 93(5):523-8. PubMed ID: 23810735
[TBL] [Abstract][Full Text] [Related]
15. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S
Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatment.
Hu Y; Zhao Q; Werngren J; Hoffner S; Diwan VK; Xu B
BMC Infect Dis; 2016 Jan; 16():4. PubMed ID: 26739444
[TBL] [Abstract][Full Text] [Related]
17. [The changes and the significance of cellular immune function in peripheral blood of patients with multidrug-resistant and extensively drug-resistant pulmonary tuberculosis].
Yang Y; Tang SJ; Zhang Q; Sun H; Liu YD; Hao XH; Yao L; Gu J
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Feb; 34(2):109-13. PubMed ID: 21426728
[TBL] [Abstract][Full Text] [Related]
18. Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis.
Abreu R; Giri P; Quinn F
Front Immunol; 2020; 11():1553. PubMed ID: 32849525
[TBL] [Abstract][Full Text] [Related]
19. Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients.
Pinheiro RO; de Oliveira EB; Dos Santos G; Sperandio da Silva GM; de Andrade Silva BJ; Teles RM; Milagres A; Sarno EN; Dalcolmo MP; Sampaio EP
Clin Exp Immunol; 2013 Feb; 171(2):210-9. PubMed ID: 23286948
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
